PureTech Health plc (PRTC) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.
The consensus price target is $57.00 (low: $44.00, high: $70.00), representing an upside of 219% from the current price $17.87.
Analysts estimate Earnings Per Share (EPS) of $-6.80 and revenue of $0.03B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.00 vs est $-6.80 (beat +129.4%). Analyst accuracy: 0%.
PRTC Stock — 12-Month Price Forecast
$57.00
▲ +218.97% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for PureTech Health plc, the average price target is $57.00, with a high forecast of $70.00, and a low forecast of $44.00.
The average price target represents a +218.97% change from the last price of $17.87.
Highest Price Target
$70.00
Average Price Target
$57.00
Lowest Price Target
$44.00
PRTC Analyst Ratings
Buy
Based on 2 analysts giving stock ratings to PureTech Health plc in the past 3 months
EPS Estimates — PRTC
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $2.00
vs Est –$6.80
▲ 440.0% off
Profitability Outlook
Company is profitable with solid earnings.
Revenue Estimates — PRTC
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.031B
▼ 606.8% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
